{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:17:17Z","timestamp":1794579437936,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":11,"publisher":"Springer New York","isbn-type":[{"value":"9781493988228","type":"print"},{"value":"9781493988235","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T00:00:00Z","timestamp":1539388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8823-5_13","type":"book-chapter","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T05:47:53Z","timestamp":1540187273000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Evolving Landscape of Designer Drugs"],"prefix":"10.1007","author":[{"given":"Sherri L.","family":"Kacinko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Papsun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,13]]},"reference":[{"key":"13_CR1","unstructured":"Kacinko SL, Papsun D (June 2016) Designer drugs keep evolving: novel psychoactive substances challenge laboratories and laws. Clinical and Forensic Toxicology News (Quarterly, AACC\/CAP), 1-8. Available from: \nhttps:\/\/www.aacc.org\/publications\/clinical-and-forensic-toxicology-news"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2307\/2187338","volume":"7","author":"Cambridge University Press","year":"1913","unstructured":"Cambridge University Press (1913) The second international opium conference. Am J Int Law 7:838\u2013847","journal-title":"Am J Int Law"},{"key":"13_CR3","unstructured":"Hoffmann, A. (1996). LSD: Completely Personal. Presentation, 1996 Worlds of Consciousness Conference. Available at \nhttp:\/\/www.maps.org\/news-letters\/v06n3\/06346hof.html\n\n."},{"key":"13_CR4","unstructured":"EMCDDA\u2013Europol (2009) Annual Report on the implementation of Council Decision 2005\/387\/JHA, European Monitoring Centre for Drugs and Drug Addiction and Europol, Publications Office of the European Union, Luxembourg"},{"key":"13_CR5","unstructured":"National Drug Early Warning System (NDEWS) \nhttps:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/national-drug-early-warning-system-ndews"},{"issue":"1","key":"13_CR6","first-page":"53","volume":"26","author":"S Gurney","year":"2014","unstructured":"Gurney S (2014) Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev 26(1):53\u201378","journal-title":"Forensic Sci Rev"},{"key":"13_CR7","doi-asserted-by":"crossref","unstructured":"Logan BK, Mohr ALA, Friscia M et al (2017) Reports of adverse events associated with use of novel psychoactive substances, 2013\u20132016: a review. J Anal Toxicol:1\u201338","DOI":"10.1093\/jat\/bkx031"},{"key":"13_CR8","first-page":"93","volume":"62","author":"TD Murphy","year":"2013","unstructured":"Murphy TD, Weidenbach KN, Van Houten C (2013) Acute kidney injury associated with synthetic cannabinoid use\u2014multiple states, 2012. MMWR Morb Mortal Wkly Rep 62:93\u201398","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"13_CR9","unstructured":"Drug Enforcement Agency, Office of Diversion Control, Drug & Chemical Identifcation Section. (2014). Phenazepam. Retrieved from \nhttp:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/phenazepam.pdf\n\n."},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00204-015-1513-x","volume":"89","author":"AM Ara\u00fajo","year":"2015","unstructured":"Ara\u00fajo AM, Carvalho F, Bastos M de L et al (2015) The hallucinogenic world of tryptamines: an updated review. Arch Toxicol 89:1151\u20131173","journal-title":"Arch Toxicol"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s13181-013-0295-x","volume":"9","author":"BV Dean","year":"2013","unstructured":"Dean BV, Stellpflug SJ, Burnett AM et al (2013) 2C or not 2C: phenethylamine designer drug review. J Med Toxicol 9:172\u2013178","journal-title":"J Med Toxicol"}],"container-title":["Methods in Molecular Biology","LC-MS in Drug Analysis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8823-5_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T05:50:41Z","timestamp":1540187441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8823-5_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,13]]},"ISBN":["9781493988228","9781493988235"],"references-count":11,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8823-5_13","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-8823-5","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,13]]}}}